AHA @ GW-ICC Joint Forum – Great Wall International Congress of Cardiology (GW-ICC) 2017 – Evaluation and Management of Hypertension

AHA @ GW-ICC Joint Forum – Great Wall International Congress of Cardiology (GW-ICC) 2017 – Evaluation and Management of Hypertension – Impact of SPRINT and Other New Evidence

It has become a tradition for world renowned cardiology associations to send delegations to GW-ICC congresses.

Professor Jeroen J. Bax, President, European Society of Cardiology (ESC), Professor John Warner, President, American Heart Association (AHA), and Professor Mary N. Walsh, President, American College of Cardiology (ACC), led delegations attending the 28^th GW-ICC, to present latest international guidance, cutting-edge diagnosis and information on treatment with emerging technologies.

Cooperation with these international societies is not limited to their attendance at GW-ICC; GW-ICC also holds reciprocal academic sessions at the annual meetings of these eminent societies, for example GW-ICC @ ACC, GW-ICC @ AHA, and GW @ ESC, to introduce important Chinese academic research.

At the 28^th GW-ICC in 2017, the AHA @ GW-ICC Joint Forum, which was held over three sessions, focused on population health, guidelines and real-world evidence; cardiovascular disease prevention: hypertension, smoking cessation and blood lipid management and systems of STEMI care.

A video of one of these 2017 sessions, Update on Practice Guidelines, is now available to view on the GW-ICC YouTube channel:

Evaluation and Management of Hypertension – Impact of SPRINT and Other New Evidence

Presenter: Sidney C. Smith, Jr., MD, FAHA, FESC, FACP, MACC, Professor of Medicine and Director of the Center for Cardiovascular Science and Medicine at the University of North Carolina, Chapel Hill, NC, USA.

Dr Smith discusses how there is strong evidence that lower is better than higher for treatment of hypertension in selected high-risk populations. More data is needed in populations not covered by SPRINT (e.g. diabetes, stroke) and on ideal combinations of antihypertensive medications considering race/ethnicity.

Further information on the 29^th GW-ICC, to be held October 11^th -14^th, 2018, in Beijing, China, is available on the congress website:

http://www.gw-icc2017.org/en/1/index.jsp

Cardiovascular Innovations and Applications (CVIA) is the official journal of the Great Wall International Cardiology Conference (GW-ICC). CVIA supports GW-ICC in its aims of leading the development of cardiovascular medicine in China, by introducing and promoting new concepts and technologies and strengthening and promoting cooperation amongst Chinese and international cardiology experts. CVIA is available on the IngentaConnect platform http://www.ingentaconnect.com/content/cscript/cvia and at https://dhn.zgc.mybluehostin.me/cvia/. Submissions may be made using Scholar One manuscripts at https:/mc04.manuscriptcentral.com/cvia-journal. There are no author submission or article processing fees.